APG-115 Clinical Trials
4 recruitingDrug
Phase 13Phase 22
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHL
Non-Hodgkins LymphomaT-Prolymphocytic Leukemia
Ascentage Pharma Group Inc.78 enrolled1 locationNCT04496349
Recruiting
Phase 1
APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors
Solid TumorNeuroblastoma
Ascentage Pharma Group Inc.100 enrolled3 locationsNCT05701306
Recruiting
Phase 1Phase 2
APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
Advanced Solid TumorLiposarcoma
Ascentage Pharma Group Inc.95 enrolled3 locationsNCT04785196
Recruiting
Phase 1
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Ascentage Pharma Group Inc.102 enrolled14 locationsNCT04275518